Blueprint specializes in systemic mastocytosis, a rare immunological disease, and other Kit-driven diseases. With this acquisition, Sanofi aims to expand its portfolio in rare immunological disease.

A demonstration plant with a capacity of 28 tons of ammonia per day will first be built at Uniper’s Gelsenkirchen-Scholven site in Germany. This project will serve as the basis for the planned hydrogen import terminal in Wilhelmshaven, northwestern Germany, where the technology will be applied on a large industrial scale.

Saipem has secured a mega EPC contract from Enilive for expanding its Venice biorefinery in Italy. The project comprises of increasing the plant's capacity from the existing 400,000 to 600,000 tons per year and the production of sustainable aviation fuel.

The Pepperl+Fuchs Group has introduced Tab-Ex 05, a new tablet which offers 5G support. Designed for use in hazardous areas, the tablet is capable of meeting the high demands of digitalized process chains in IOT and Industry 4.0 scenarios.

Vega’s sensor solutions are being supplied to Nordex Electrolyzers’ 500-kW prototype for producing green hydrogen. The prototype can produce over 10 kilograms of hydrogen per hour and is installed in a modular container system.

A breakthrough enzyme discovered in Brazil could transform biofuel production. Named Celoce, the natural protein efficiently breaks down cellulose — one of biomass's toughest components — offering a powerful new tool for producing second-generation ethanol from agricultural waste.

Koppö Energia has awarded the FEED for an e-methanol plant using technology from Thyssenkrupp Uhde for a power-to-X project in Finland. The project is intended to contribute to the production of CO₂-reduced fuels.

Honeywell has successfully purchased Air Products’ LNG Process Technology and Equipment Business for 1.81 billion dollars. The move is in line with Air Products’ goal of focusing on its two-pillar growth strategy to profitably grow its core industrial gases and related equipment businesses, and to deliver clean hydrogen at scale.

Sanofi and Blueprint Medicines Corporation have entered into an agreement under which Sanofi plans to acquire the US biopharmaceutical company Blueprint for 9.1 billion dollars.

Natural State Renewables along with its partners Axens and Thyssenkrupp Uhde have achieved a major milestone in producing sustainable aviation fuels from surplus forest biomass.